Nickolas Papadopoulos
#142,995
Most Influential Person Now
Researcher
Nickolas Papadopoulos's AcademicInfluence.com Rankings
Nickolas Papadopouloscomputer-science Degrees
Computer Science
#6986
World Rank
#7356
Historical Rank
Computational Linguistics
#1314
World Rank
#1328
Historical Rank
Machine Learning
#2437
World Rank
#2468
Historical Rank
Artificial Intelligence
#2720
World Rank
#2762
Historical Rank
Download Badge
Computer Science
Nickolas Papadopoulos's Degrees
- PhD Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Nickolas Papadopoulos Influential?
(Suggest an Edit or Addition)Nickolas Papadopoulos's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cancer Genome Landscapes (2013) (6203)
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme (2008) (4366)
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade (2017) (4313)
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses (2008) (3758)
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. (2015) (3718)
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies (2014) (3526)
- The Consensus Coding Sequences of Human Breast and Colorectal Cancers (2006) (2878)
- The Genomic Landscapes of Human Breast and Colorectal Cancers (2007) (2549)
- Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer (1993) (2347)
- Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 (2011) (1652)
- Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer (1994) (1620)
- Detection and localization of surgically resectable cancers with a multi-analyte blood test (2018) (1556)
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors (2011) (1474)
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal (2013) (1148)
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma (2010) (1123)
- The molecular basis of Turcot's syndrome. (1995) (1106)
- The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. (2015) (1068)
- Hypermutability and mismatch repair deficiency in RER+ tumor cells (1993) (1060)
- Detection and quantification of rare mutations with massively parallel sequencing (2011) (992)
- Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients (1996) (975)
- Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer (2016) (922)
- Altered Telomeres in Tumors with ATRX and DAXX Mutations (2011) (894)
- Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells (2009) (848)
- Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development (2011) (711)
- The Genetic Landscape of the Childhood Cancer Medulloblastoma (2011) (711)
- Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH (2015) (646)
- Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing (2012) (568)
- Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas (2013) (555)
- Molecular determinants of dysplasia in colorectal lesions. (1994) (554)
- Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways (2011) (535)
- Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas (2012) (532)
- The Antisense Transcriptomes of Human Cells (2008) (526)
- Mutations of GTBP in genetically unstable cells. (1995) (508)
- Heteroplasmic mitochondrial DNA mutations in normal and tumor cells (2010) (501)
- Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway (2012) (492)
- Deletion of p16 and p15 genes in brain tumors. (1994) (464)
- Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells (2014) (461)
- Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. (2015) (461)
- A public database for gene expression in human cancers. (1999) (447)
- ATM mutations in patients with hereditary pancreatic cancer. (2012) (427)
- Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma (2011) (405)
- Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma (2011) (400)
- Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers (2017) (387)
- Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma (2012) (379)
- Cancer‐Associated Mutations in Endometriosis without Cancer (2017) (375)
- Genetic instability occurs in the majority of young patients with colorectal cancer (1995) (372)
- APC mutations in colorectal tumors with mismatch repair deficiency. (1996) (364)
- Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer (2014) (361)
- Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. (2012) (344)
- Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas (2015) (343)
- A combination of molecular markers and clinical features improve the classification of pancreatic cysts. (2015) (339)
- CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome (1999) (322)
- Sensitive digital quantification of DNA methylation in clinical samples (2009) (319)
- A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53 (2009) (304)
- Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers (2008) (300)
- Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord (2015) (290)
- Evaluating the evaluation of cancer driver genes (2016) (285)
- Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer. (2019) (282)
- Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer (2017) (281)
- Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types (2011) (278)
- Conversion of diploidy to haploidy (2000) (274)
- Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses (2014) (270)
- Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers (2013) (269)
- Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer. (2016) (261)
- Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention (2020) (257)
- Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias. (1995) (225)
- Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. (2007) (224)
- Mutational Signature of Aristolochic Acid Exposure as Revealed by Whole-Exome Sequencing (2013) (224)
- Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors (2014) (218)
- TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine. (2013) (212)
- Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study (2018) (207)
- Paradoxical inhibition of solid tumor cell growth by bcl2. (1994) (207)
- Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS. (2013) (204)
- The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia? (2014) (201)
- Molecular basis of HNPCC: Mutations of MMR genes (1997) (201)
- Low‐grade serous carcinomas of the ovary contain very few point mutations (2012) (191)
- Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers. (2016) (186)
- Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome (2018) (173)
- Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers (2015) (164)
- Serial assessment of human tumor burdens in mice by the analysis of circulating DNA. (2007) (155)
- Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing (2016) (154)
- Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers (2018) (154)
- A multidimensional analysis of genes mutated in breast and colorectal cancers. (2007) (148)
- APC/CTNNB1 (β‐catenin) pathway alterations in human prostate cancers (2002) (141)
- The role of companion diagnostics in the development and use of mutation-targeted cancer therapies (2006) (141)
- Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. (1995) (139)
- Whole‐exome sequencing of pancreatic neoplasms with acinar differentiation (2014) (138)
- Targeting a neoantigen derived from a common TP53 mutation (2021) (134)
- Genomic organization of the human PMS2 gene family. (1995) (125)
- Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation (2010) (125)
- Analysis of masked mutations in familial adenomatous polyposis. (1999) (125)
- Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer. (2019) (123)
- Mutant proteins as cancer-specific biomarkers (2011) (117)
- Applications of liquid biopsies for cancer (2019) (116)
- Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy (2018) (114)
- Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer. (2022) (114)
- APC gene mutations in the mutation cluster region are rare in esophageal cancers. (1994) (95)
- How liquid biopsies can change clinical practice in oncology. (2019) (95)
- Global identification of MLL2-targeted loci reveals MLL2’s role in diverse signaling pathways (2012) (94)
- A multimodality test to guide the management of patients with a pancreatic cyst (2019) (94)
- Exomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomas (2014) (88)
- Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists. (2020) (86)
- APC/CTNNB1 (beta-catenin) pathway alterations in human prostate cancers. (2002) (80)
- How liquid biopsies can change clinical practice in oncology. (2019) (80)
- Precancerous neoplastic cells can move through the pancreatic ductal system (2018) (75)
- Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing Analysis (2015) (75)
- Bispecific antibodies targeting mutant RAS neoantigens (2021) (73)
- Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer. (2019) (72)
- Lavage of the Uterine Cavity for Molecular Detection of Müllerian Duct Carcinomas: A Proof-of-Concept Study (2015) (70)
- Clinical, genomic, and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke (2015) (70)
- IgH gene rearrangements as plasma biomarkers in Non-Hodgkin's Lymphoma patients (2011) (69)
- Exomic Sequencing of Four Rare Central Nervous System Tumor Types (2013) (65)
- Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemia. (2011) (65)
- Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma (2016) (65)
- ATR mediates cisplatin resistance in a p53 genotype-specific manner (2010) (63)
- FAST-SeqS: A Simple and Efficient Method for the Detection of Aneuploidy by Massively Parallel Sequencing (2012) (59)
- Aristolochic Acid in the Etiology of Renal Cell Carcinoma (2016) (59)
- Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study (2021) (55)
- Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies (2020) (53)
- Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer. (2005) (52)
- Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types. (2004) (50)
- Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localised pancreatic cancer. (2019) (47)
- Familial and sporadic pancreatic cancer share the same molecular pathogenesis (2015) (39)
- Genetic Classification of Gliomas: Refining Histopathology. (2015) (38)
- Monoallelic mutation analysis (MAMA) for identifying germline mutations (1995) (38)
- Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival (2020) (38)
- Assessing aneuploidy with repetitive element sequencing (2019) (37)
- Targeting public neoantigens for cancer immunotherapy (2021) (36)
- Diagnostic potential of tumor DNA from ovarian cyst fluid (2016) (35)
- High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma (2016) (35)
- Generation of MANAbodies specific to HLA-restricted epitopes encoded by somatically mutated genes (2015) (35)
- Detection of aneuploidy in patients with cancer through amplification of long interspersed nucleotide elements (LINEs) (2018) (34)
- High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder (2016) (34)
- A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts (2017) (34)
- Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1 (2019) (33)
- Transcriptional control of the chicken cardiac myosin light-chain gene is mediated by two AT-rich cis-acting DNA elements and binding of serum response factor (1993) (32)
- The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints (2015) (31)
- Detection of Somatic TP53 Mutations in Tampons of Patients With High-Grade Serous Ovarian Cancer (2014) (31)
- Incidence and Distribution of UroSEEK Gene Panel in a Multi-institutional Cohort of Bladder Urothelial Carcinoma (2019) (30)
- Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder. (2016) (30)
- Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia (2011) (30)
- Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations. (2019) (28)
- Conversion of diploidy to haploidy - Individuals susceptible to multigene disorders may now be spotted more easily. (2000) (27)
- Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder (2017) (26)
- Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology (2019) (25)
- Selected reaction monitoring approach for validating peptide biomarkers (2017) (24)
- Targeting loss of heterozygosity for cancer-specific immunotherapy (2021) (24)
- Direct Detection and Quantification of Neoantigens (2019) (24)
- Characterization of a t(5;8)(q31;q21) translocation in a patient with mental retardation and congenital heart disease: implications for involvement of RUNX1T1 in human brain and heart development (2009) (23)
- Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma (2018) (22)
- Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands (2021) (21)
- Epigenetic remodelling and dysregulation of DLGAP4 is linked with early-onset cerebellar ataxia (2014) (19)
- Alpha-1 adrenergic receptor antagonists for preventing acute respiratory distress syndrome and death from cytokine storm syndrome. (2020) (18)
- Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC). (2014) (18)
- Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection (2020) (18)
- Serial circulating tumor DNA (ctDNA) analysis as a prognostic marker and a real-time indicator of adjuvant chemotherapy (CT) efficacy in stage III colon cancer (CC). (2018) (18)
- Pathophysiology of ctDNA Release into the Circulation and Its Characteristics: What Is Important for Clinical Applications. (2020) (17)
- Targeting the catecholamine-cytokine axis to prevent SARS-CoV-2 cytokine storm syndrome (2020) (17)
- Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers (2021) (17)
- The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with nonspecific findings on standard investigations (2019) (15)
- TCR β chain–directed bispecific antibodies for the treatment of T cell cancers (2021) (15)
- Bisulfite-converted duplexes for the strand-specific detection and quantification of rare mutations (2017) (15)
- Potential role of circulating tumor DNA (ctDNA) in the early diagnosis and post-operative management of localised pancreatic cancer. (2017) (14)
- Ultrasensitive detection of tumor‐specific mutations in saliva of patients with oral cavity squamous cell carcinoma (2020) (14)
- Serial circulating tumor DNA (ctDNA) and recurrence risk in patients (pts) with resectable colorectal liver metastasis (CLM). (2016) (13)
- Response to Comments on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers" (2007) (13)
- The potential of circulating tumor DNA (ctDNA) to guide adjuvant chemotherapy decision making in locally advanced rectal cancer (LARC). (2017) (12)
- Microsatellite instability (MSI) in non-colonic, non-HNPCC tumors: 'instable' evidence? (1999) (10)
- An engineered antibody fragment targeting mutant β-catenin via major histocompatibility complex I neoantigen presentation (2019) (10)
- Circulating tumor DNA (ctDNA) in nonmetastatic colorectal cancer (CRC): Potential role as a screening tool. (2015) (10)
- Molecular and Pathology Features of Colorectal Tumors and Patient Outcomes Are Associated with Fusobacterium nucleatum and Its Subspecies animalis (2021) (9)
- Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy (2018) (9)
- The potential of circulating tumor DNA (ctDNA) to reshape the design of clinical trials testing adjuvant therapy in patients with early stage cancers. (2016) (8)
- Progression model of prostate cancer. (2003) (8)
- Identification of novel noncoding transcripts in telomerase-negative yeast using RNA-seq (2016) (8)
- Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens (2021) (8)
- Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (2022) (8)
- Massively Parallel Sequencing of Esophageal Brushings Enables an Aneuploidy-Based Classification of Patients with Barrett's Esophagus. (2021) (8)
- Genetic landscape of extreme responders with anaplastic oligodendroglioma (2017) (8)
- Breast and Colorectal Cancers The Consensus Coding Sequences of Human (2007) (6)
- Absence of mutations in DICE1/DDX26 gene in human cancer cell lines with frequent 13q14 deletions. (2005) (6)
- DNA measurement in pituitary adenomas assessed on imprints by image analysis. (1996) (6)
- Abstract 451: The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints (2015) (6)
- Intraductal papillary mucinous neoplasm in a neonate with congenital hyperinsulinism and a de novo germline SKIL gene mutation. (2015) (5)
- Circulating tumor DNA as a prognostic biomarker in early stage pancreatic cancer. (2018) (5)
- Non-invasive detection of bladder cancer through the analysis of driver gene mutations and aneuploidy (2017) (5)
- 318MO Circulating tumour DNA (ctDNA) dynamics, CEA and sites of recurrence for the randomised DYNAMIC study: Adjuvant chemotherapy (ACT) guided by ctDNA analysis in stage II colon cancer (CC) (2022) (5)
- Conversion technology and its role in genetic testing of inherited diseases (2003) (5)
- Sequence and expression analysis of gaps in human chromosome 20 (2012) (5)
- Glioblastoma Multiforme An Integrated Genomic Analysis of Human (2010) (5)
- Limited detection of IgH gene rearrangements in plasma of patients with primary central nervous system lymphoma (2013) (4)
- Multicancer early detection test: Preclinical, translational, and clinical evidence–generation plan and provocative questions (2022) (3)
- Tumor DNA as a Cancer Biomarker through the Lens of Colorectal Neoplasia (2020) (3)
- Abstract 20: Whole exome sequencing of aristolochic acid induced upper urothelial carcinomas. (2012) (2)
- Ras/Raf and Their Influence in Glycolysis in Colon Cancer (2012) (2)
- Molecular Mechanisms of Cystic Neoplasia (2018) (2)
- Abstract 4137: Clonal evolution defines the natural history of metastatic pancreatic cancer (2015) (2)
- Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma (2021) (2)
- A pooled analysis of multicenter cohort studies of post-surgery circulating tumor DNA (ctDNA) in early stage colorectal cancer (CRC). (2019) (2)
- Material for The Antisense Transcriptomes of Human Cells (2008) (2)
- Author response: Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection (2021) (2)
- Germline missense mutations in mismatch-repair genes and genetic testing for HNPCC (2007) (1)
- Colorectal Cancer Genome and Its Implications (2013) (1)
- 1124 A MULTI-MODALITY TEST TO GUIDE THE MANAGEMENT OF PATIENTS WITH PANCREATIC CYSTS (2019) (1)
- Alpha-1 adrenergic receptor antagonists prevent acute respiratory distress syndrome and death: implications for Coronavirus disease 2019 (2020) (1)
- Abstract IA17: Non-invasive detection of somatic mutations in the management of CRC (2017) (1)
- MP03-01 CLINICAL, PATHOLOGIC AND GENOMIC PROFILES OF EXCEPTIONAL RESPONDERS TO ANTI-PD1 THERAPY IN RENAL CELL CARCINOMA (2016) (1)
- Non-invasive detection of upper tract urothelial carcinomas through the analysis of driver gene mutations and aneuploidy in urine (2017) (1)
- Abstract IA04: ATRX mutations in human carcinogenesis (2013) (1)
- Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1 (2019) (1)
- Accurate genetic testing platform based on haploid templates: Use in inheritable colon cancer. (2005) (1)
- Correction to: Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology (2022) (1)
- Targeting MHC-linked wild type p53 with TCR mimic single chain diabody for cancer immunotherapy. (2019) (1)
- Durable Responses to PD-1 Blockade in Mismatch-Repair Deficient Cancers, Independent of Tissue Origin (2017) (1)
- Software for Assessing aneuploidy with repetitive element sequencing (2020) (1)
- Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma (2018) (1)
- Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (2023) (0)
- Molecular Genetics of Neuroendocrine Tumors (2018) (0)
- Dissecting the specificity of a TCR-mimic antibody targeting TP53 R175H mutation-derived neoantigen (2020) (0)
- Author response: Diagnostic potential of tumor DNA from ovarian cyst fluid (2016) (0)
- The rapid and highly parallel identification of antibodies with defined biological activities by SLISY (2023) (0)
- Conversion technology and cancer predispositions. (2003) (0)
- Analysis of Circulating DNA Serial Assessment of Human Tumor Burdens in Mice by the (2007) (0)
- GENE-01. THE MUTATIONAL LANDSCAPE OF PRIMARY CHORDOMAS AND THEIR SENSITIVE DETECTION IN PLASMA ctDNA BY MULTIPLE NEXT GENERATION SEQUENCING TECHNOLOGIES (2019) (0)
- An isogenic cell line panel for sequence-based screening of targeted anticancer drugs (2021) (0)
- Abstract CT022: A first-of-its-kind prospective study of a multi-cancer blood test to screen and manage 10,000 women with no history of cancer (2020) (0)
- Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome (2018) (0)
- Abstract PR3: Exome sequencing of head and neck squamous cell carcinoma reveals a higher frequency of mutations in TP53 among African Americans (2011) (0)
- Isaac Kinde Endometrial Cancers Evaluation of DNA from the Papanicolaou Test to Detect Ovarian (2013) (0)
- Leary Patients with Whole-Genome Sequencing Detection of Chromosomal Alterations in the Circulation of Cancer (2012) (0)
- Inpatient Administration of Alpha-1-Adrenergic Receptor Blocking Agents Reduces Mortality in Male COVID-19 Patients (2022) (0)
- Abstract B65: Precompetitive collaboration on liquid biopsy for early cancer assessment (2020) (0)
- Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1 (Journal for Immuno Therapy of Cancer (2019) 7 (40) DOI: 10.1186/s40425-018-0492-x) (2019) (0)
- Genetic landscape of extreme responders with anaplastic oligodendroglioma: NRG Oncology/RTOG 9402. (2016) (0)
- Abstract LB095: Hybrid TCR-CAR design surpasses conventional CARs and patient-derived TCRs in targeting an ultra-low-density neoantigen (2023) (0)
- Detection of rare mutations, copy number variation, and DNA methylation in the same template DNA molecules (2022) (0)
- Detection of rare mutations, copy number alterations, and methylation in the same template DNA molecules. (2023) (0)
- UROSEEK: A NOVEL NON‐INVASIVE MOLECULAR METHOD FOR EARLY DETECTION OF BLADDER CANCER: MP65‐13 (2018) (0)
- Supplement to: cancer associated mutations in non-cancer associated endometriosis (2017) (0)
- 597 Molecular Markers Help Define Cyst Type in the Pancreas: An International, Multicenter Study of Over 300 Cysts (2016) (0)
- Direct Detection and Quantification of Neo-antigens (2019) (0)
- UROSEEK: A NOVEL NON‐INVASIVE MOLECULAR ASSAY FOR SURVEILLANCE OF BLADDER CANCER: MP65‐14 (2018) (0)
- Correction: Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma (2017) (0)
- A retrospective clinical study supporting the rationale for trials of Alpha-1 Adrenoreceptor Antagonists to prevent cytokine storm and severe COVID-19 (2020) (0)
- Abstract IA05: ctDNA and MRD in colorectal cancer: Time to reinvent adjuvant clinical trials (2020) (0)
- Abstract NG01: Accumulation of somatic mutations in normal and cancerous tissues with age (2016) (0)
- IL-2 AUGMENTS IMMTAC-DEPENDENT T CELL ACTIVATION AND TUMOUR CELL KILLING TARGETING A SHARED TP53 NEOANTIGEN WITH BISPECIFIC T CELL RETARGETING ANTIBODY (2020) (0)
- Familial and sporadic pancreatic cancer share the same molecular pathogenesis (2014) (0)
- 629 Targeting a shared TP53 neoantigen with bispecific T cell retargeting antibody (2020) (0)
- University of Southern Denmark Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers (2018) (0)
- Assignment of the Human p27Kipl Gene to 12pl3 and Its Analysis in Leukemias1 (1995) (0)
- Limits to the Human Cancer Genome Project ? (0)
- Exomic sequencing of pancreatic neuroendocrine tumors: Detection of alterations in chromatin remodeling and mTOR pathway genes. (2011) (0)
- Epigenetic Profiling and Epigenetic Therapy in Cancer (2008) (0)
- Author Correction: Targeting public neoantigens for cancer immunotherapy (2021) (0)
- identifying cancer patients from GC-patterned fragment ends of cell-free DNA (2022) (0)
- Mapping genes for oligodendroglioma. (2012) (0)
- Abstract 2951: Vitamin C is selectively toxic to cancer cells harboring KRAS or BRAF mutations by targeting GAPDH (2014) (0)
- 17. Small cell osteosarcoma (1993) (0)
- The Big Data cancer results are reported in Bert (0)
- Seq-ing the SINEs of Central Nervous System Tumors in Cerebrospinal Fluid DNA (2022) (0)
- UroSEEK signature in invasive bladder cancer (2018) (0)
- Precancerous neoplastic cells can move through the pancreatic ductal system (2018) (0)
- Heterogeneityof LipoproteinElectrophoreticPatternsin PatientswithType HaHyperlipoproteinemia (2004) (0)
- Abstract 127: The genomic landscapes of inflammatory bowel disease-associated colorectal cancers (2016) (0)
- Deletion ofpl 6 and pl 5 Genes in Brain Tumors 1 (2006) (0)
- Characterization of the MLC box: A conserved {\it cis\/}-acting DNA element present in the chicken MLC1s/1c gene (1992) (0)
- 2777 Lavage of the uterine cavity for early and differential diagnosis of serous ovarian cancer (2015) (0)
- Abstract C60: Vitamin C inhibits the survival and growth of colorectal cancer cells with KRAS or BRAF mutations (2013) (0)
- 44 MASSIVELY PARALLEL SEQUENCING OF ESOPHAGEAL BRUSHINGS ENABLES AN ANEUPLOIDY-BASED CLASSIFICATION OF PATIENTS WITH BARRETT'S ESOPHAGUS (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Nickolas Papadopoulos?
Nickolas Papadopoulos is affiliated with the following schools:
